While prior literature cites a 510% defect rate among women with pregestational diabetes, this study did not report any significant pregnancy losses following the use of GLP-1RA (92)
The drug's pharmacokinetics are not significantly altered by hour-of-day injection timing because of its long half-life
Manufacturers agreed to the lower Medicare price back in November on one condition, that private Part D plans would cover GLP-1s for every use at a $50 copay
Similarly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for the treatment of type 2 diabetes, have demonstrated promising cognitive benefits, potentially mediated through improved insulin signaling, neuronal survival, and reduced -amyloid (A) and tau burden
Sometimes, when blood sugar drops quickly, it can cause diabetic retinopathy to get worse for a short time